b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plosone" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2797643/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Intracranial Administration of P Gene siRNA Protects Mice from Lethal Chandipura Virus Encephalitis</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797643/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS ONE" /><meta name="citation_title" content="Intracranial Administration of P Gene siRNA Protects Mice from Lethal Chandipura Virus Encephalitis" /><meta name="citation_authors" content="Satyendra Kumar, Vidya A. Arankalle" /><meta name="citation_date" content="2010" /><meta name="citation_issue" content="1" /><meta name="citation_volume" content="5" /><meta name="citation_doi" content="10.1371/journal.pone.0008615" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2797643/?report=abstract" /><meta name="citation_pmid" content="20062542" /><meta name="DC.Title" content="Intracranial Administration of P Gene siRNA Protects Mice from Lethal Chandipura Virus Encephalitis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Satyendra Kumar" /><meta name="DC.Contributor" content="Vidya A. Arankalle" /><meta name="DC.Date" content="2010" /><meta name="DC.Identifier" content="10.1371/journal.pone.0008615" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Intracranial Administration of P Gene siRNA Protects Mice from Lethal Chandipura Virus Encephalitis" /><meta property="og:type" content="article" /><meta property="og:description" content="In parts of India, Chandipura Virus (CHPV) has emerged as an encephalitis causing pathogen in both epidemic and sporadic forms. This pediatric disease follows rapid course leading to 55\xe2\x80\x9375% mortality. In the absence of specific treatment, ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797643/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2797643/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2797643/pdf/pone.0008615.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BA949E9A44401000000000290028F.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/183607/">v.5(1); 2010</a></li><li class="accid">PMC2797643</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0008615" ref="reftype=publisher&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS One</span>. 2010; 5(1): e8615. </span></div><div><span class="fm-vol-iss-date">Published online 2010 Jan 7. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.pone.0008615" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0008615</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2797643</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20062542">20062542</a></div></div></div></div><h1 class="content-title">Intracranial Administration of P Gene siRNA Protects Mice from Lethal Chandipura Virus Encephalitis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Kumar%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20062542" class="affpopup" co-rid="_co_idm139860037879728" co-class="co-affbox">Satyendra Kumar</a><sup></sup> and  <a href="/pubmed/?term=Arankalle%20VA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20062542" class="affpopup" co-rid="_co_idm139859962997072" co-class="co-affbox">Vidya A. Arankalle</a><sup></sup><sup>\n&#x0002a;\n</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139860037879728"><h3 class="no_margin">Satyendra Kumar</h3><p>  National Institute of Virology, Pune, India,   </p><div>Find articles by <a href="/pubmed/?term=Kumar%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20062542">Satyendra Kumar</a></div></div><div id="_co_idm139859962997072"><h3 class="no_margin">Vidya A. Arankalle</h3><p>  National Institute of Virology, Pune, India,   </p><div>Find articles by <a href="/pubmed/?term=Arankalle%20VA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20062542">Vidya A. Arankalle</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Bradley S. Schneider, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139859958143824_ai idm139860037879856_ai idm139859964523808_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139859958143824_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139859958143824_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139859958143824_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  National Institute of Virology, Pune, India,   </div><div class="fm-affl" lang="en" id="edit1">Institut Pasteur, France</div><div id="cor1">&#x0002a; E-mail: <a href="mailto:dev@null" data-email="moc.oohay@ellaknarav" class="oemail">moc.oohay@ellaknarav</a></div><div><p id="__p1" class="p p-first-last">Conceived and designed the experiments: SK VAA. Performed the experiments: SK. Analyzed the data: SK VAA. Wrote the paper: SK VAA.</p></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139859958143824_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Sep 29; Accepted 2009 Dec 8.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139859958143824_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> Kumar, Arankalle.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2797643/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139860040929568" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139860040929568title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p2" class="p p-first-last">In parts of India, Chandipura Virus (CHPV) has emerged as an encephalitis causing pathogen in both epidemic and sporadic forms. This pediatric disease follows rapid course leading to 55&#x02013;75&#x00025; mortality. In the absence of specific treatment, effectiveness of RNA interference (RNAi) was evaluated.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods and Findings</h3><p id="__p3" class="p p-first-last">Efficacy of synthetic short interfering RNA (siRNA) or short hairpin RNA (shRNA) in protecting mice from CHPV infection was assessed. The target genes were P and M genes primarily because important role of the former in viral replication and lethal nature of the latter. Real time one step RT-PCR and plaque assay were used for the assessment of gene silencing. Using pAcGFP1N1-CHPV-P, we showed that P-2 siRNA was most efficient in reducing the expression of P gene <em>in-vitro</em>. Both quantitative assays documented 2logs reduction in the virus titer when P-2, M-5 or M-6 siRNAs were transfected 2hr post infection (PI). Use of these siRNAs in combination did not result in enhanced efficiency. P-2 siRNA was found to tolerate four mismatches in the center. As compared to five different shRNAs, P-2 siRNA was most effective in inhibiting CHPV replication. An extended survival was noted when mice infected intracranially with 100 LD<sub>50</sub> CHPV were treated with cationic lipid complexed 5 &#x000b5;g P-2 siRNA simultaneously. Infection with 10LD<sub>50</sub> and treatment with two doses of siRNA first, simultaneously and second 24 hr PI, resulted in 70&#x00025; survival. Surviving mice showed 4logs less CHPV titers in brain without histopathological changes or antibody response. Gene expression profiles of P-2 siRNA treated mice showed no interferon response. First dose of siRNA at 2hr or 4hr PI with second dose at 24hr resulted in 40&#x00025; and 20&#x00025; survival respectively suggesting potential application in therapy.</p></div><div id="__sec3" class="sec sec-last"><h3 id="__sec3title">Conclusions</h3><p id="__p4" class="p p-first-last">The results highlight therapeutic potential of siRNA in treating rapid and fatal Chandipura encephalitis.</p></div></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p id="__p5" class="p p-first">Chandipura virus (CHPV), an emerging encephalitis-causing pathogen in India belongs to family <em>Rhabdoviridae</em> and genus vesiculovirus. Outbreaks of CHPV have been reported from the states of Andhra Pradesh <a href="#pone.0008615-Rao1" rid="pone.0008615-Rao1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809905">[1]</a>, Gujarat <a href="#pone.0008615-Chadha1" rid="pone.0008615-Chadha1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947068">[2]</a> and Maharashtra [National Institute of Virology (NIV), unpublished data] with mortality varying from 55&#x02013;75&#x00025; in children. In an endemic area, sporadic disease has also been recorded <a href="#pone.0008615-Tandale1" rid="pone.0008615-Tandale1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809904">[3]</a>. CHPV has a negative sense RNA genome of approximately 11.0 Kb encoding 5 different proteins; nucleocapsid (N) protein, phosphoprotein (P) protein, matrix (M) protein, glycoprotein (G) protein and large (L) protein. The P protein has important functions in the virus life cycle, both in transcription and replication <a href="#pone.0008615-Basak1" rid="pone.0008615-Basak1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947065">[4]</a>\n</p><p id="__p6">RNA interference (RNAi) is a post-transcriptional process triggered by the introduction of double-stranded RNA (dsRNA), which is subsequently cleaved by Dicer into 21&#x02013;23 nt small interfering RNAs (siRNA). The siRNAs are then unwound by RISC (RNA induced silencing complex) in the presence of ATP. The activated RISC binds and degrades target mRNA guided by the single strand of the siRNA <a href="#pone.0008615-Dixon1" rid="pone.0008615-Dixon1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809900">[5]</a>&#x02013;<a href="#pone.0008615-Hannon1" rid="pone.0008615-Hannon1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809891">[12]</a>.</p><p id="__p7">In recent years, RNAi has emerged as a powerful tool for gene silencing with a potential for therapeutic use in viral infections such as Human immunodeficiency virus (HIV) <a href="#pone.0008615-Novina1" rid="pone.0008615-Novina1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809875">[13]</a> Influenza <a href="#pone.0008615-Bennink1" rid="pone.0008615-Bennink1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809883">[14]</a>, Respiratory syncytial virus (RSV) <a href="#pone.0008615-Bitko1" rid="pone.0008615-Bitko1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809893">[15]</a>, SARS coronavirus <a href="#pone.0008615-Li1" rid="pone.0008615-Li1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809885">[16]</a> and Ebola virus <a href="#pone.0008615-Geisbert1" rid="pone.0008615-Geisbert1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809873">[17]</a>.</p><p id="__p8">Several studies have shown that the central nervous system (CNS) is also acquiescent to RNAi as in the case of brain cancer <a href="#pone.0008615-Zhang1" rid="pone.0008615-Zhang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809901">[18]</a>, Spinocerebellar ataxia <a href="#pone.0008615-Xia1" rid="pone.0008615-Xia1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809889">[19]</a>. Intracranial injection of siRNA has shown immense potential in suppressing encephalitis caused by two flaviviruses, JEV (Japanese encephalitis virus) and WNV (West Nile virus) <a href="#pone.0008615-Kumar1" rid="pone.0008615-Kumar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947066">[20]</a>. Control of non-segmented negative-strand RNA virus replication in culture cells by siRNA has been well documented <a href="#pone.0008615-Barik1" rid="pone.0008615-Barik1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809880">[21]</a>. A recent study has shown inhibition of rabies virus replication by multiple artificial microRNAs (amiRNA) in Neuro 2a cells <a href="#pone.0008615-Israsena1" rid="pone.0008615-Israsena1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947070">[22]</a>.</p><p id="__p9" class="p p-last">Considering the recent emergence of a rapidly progressing viral infection leading to encephalitis with high fatality proportion in children from India and the absence of any specific treatment, RNAi based interventions were explored to suppress CHPV infection in mice.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Materials and Methods</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Cells and Virus used in study</h3><p id="__p10" class="p p-first-last">Human embryonic Kidney (HEK)-293 cells were used for the siRNA studies and Vero E6 cells were used for the plaque assay. Chandipura Virus 034627, isolated during 2003 Andhra Pradesh epidemic <a href="#pone.0008615-Rao1" rid="pone.0008615-Rao1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809902">[1]</a> was used throughout the study.</p></div><div id="s2b" class="sec"><h3 id="s2btitle">Cloning and expression of P gene of CHPV in pAcGFP1N1</h3><p id="__p11" class="p p-first-last">P gene of CHPV was amplified by reverse transcriptase &#x02013; polymerase chain reaction (RT-PCR) using PFloF1 (<em class="gene">5&#x02032;-TCTCGAGCTCAAGCTCCACCATGGAAGACTCTCAACTAT-3&#x02032;</em>) and PGFPR1 (<em class="gene">5&#x02032;-CCGCGGTACCGTCGAATTGAACTGGGGTTCAAG-3&#x02032;</em>) primers without stop codon and cloned into pAcGFP1N1 vector (named pAcGFP1N1-CHPV-P). HEK-293 cells were transfected with 2 &#x000b5;g each of pAcGFP1N1 and pAcGFP1N1-CHPV-P. Transfected cells were observed under florescent microscope periodically to check the expression of green fluorescent protein (GFP) fused CHPV P protein and confirmed by western blotting using anti-GFP antibodies (Invitrogen, Carlsbad, CA, USA).</p></div><div id="s2c" class="sec"><h3 id="s2ctitle">Design and synthesis of siRNA</h3><p id="__p12" class="p p-first">All CHPV sequences present in the GenBank <a href="#pone.0008615-Arankalle1" rid="pone.0008615-Arankalle1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809886">[23]</a> and the sequences of the new isolates generated in the lab (NIV, unpublished data) were used to design the siRNA. All siRNAs were designed using HP OnGuard siRNA design. (<a href="/pmc/articles/PMC2797643/table/pone-0008615-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0008615-t001" rid-ob="ob-pone-0008615-t001" co-legend-rid=""><span>Table 1</span></a> and <a href="/pmc/articles/PMC2797643/figure/pone-0008615-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g001" rid-ob="ob-pone-0008615-g001" co-legend-rid="lgnd_pone-0008615-g001"><span>Fig 1</span></a>). Four and 8 siRNAs were synthesized for P gene and M gene respectively targeting cDNA (&#x0002b;) strand. Negative control siRNA (ncsiRNA) with no significant homology to any known mammalian gene was used as a non-silencing control in all RNAi experiments and purchased from qiagen (Catalog number 1027280) and negative control plasmid (NCP) was used in shRNA experiments (Ambion, USA).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g001" co-legend-rid="lgnd_pone-0008615-g001"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g001/" target="figure" rid-figpopup="pone-0008615-g001" rid-ob="ob-pone-0008615-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139859999834528" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g001.jpg" /></a></div><div id="largeobj_idm139859999834528" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g001"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g001/" target="figure" rid-figpopup="pone-0008615-g001" rid-ob="ob-pone-0008615-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Schematic representation of gene arrangement in CHPV and siRNAs used.</strong><p id="__p14">P and M genes were targeted for siRNA synthesis. The numbers were assigned arbitrarily and do not indicate location (refer <a href="/pmc/articles/PMC2797643/table/pone-0008615-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0008615-t001" rid-ob="ob-pone-0008615-t001" co-legend-rid=""><span>table 1</span></a> for correct location of siRNA). Different siRNA used to determine tolerance for mismatches using P-2 siRNA number in parentheses represent the positions at which mismatches were incorporated (For sequence of P-2 siRNA mutants refer <a href="/pmc/articles/PMC2797643/table/pone-0008615-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0008615-t002" rid-ob="ob-pone-0008615-t002" co-legend-rid=""><span>table 2</span></a>).</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0008615-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Sequences of the siRNAs (target) located in P gene [CIN0327R (<a id="__tag_671810021" class="tag_hotlink" href="/nuccore/AY614726" ref="/nuccore/AY614726"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY614726","term_id":"52547853","term_text":"AY614726"}}</span>AY614726</a>)] and M gene (<a id="__tag_671810022" class="tag_hotlink" href="/nuccore/AF128868" ref="/nuccore/AF128868"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AF128868","term_id":"4583436","term_text":"AF128868"}}</span>AF128868</a>).</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139859959125696" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Sequences</td><td align="left" rowspan="1" colspan="1">Location</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">P-1</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">AGCAATTGATAAAGAATTCAT</em>\n</td><td align="left" rowspan="1" colspan="1">1968&#x02013;1988</td></tr><tr><td align="left" rowspan="1" colspan="1">P-2</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">ACCGAATCACCTGGCTCCAAA</em>\n</td><td align="left" rowspan="1" colspan="1">1894&#x02013;1914</td></tr><tr><td align="left" rowspan="1" colspan="1">P-3</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CAGTTCAATTGAAATGATGCA</em>\n</td><td align="left" rowspan="1" colspan="1">2173&#x02013;2193</td></tr><tr><td align="left" rowspan="1" colspan="1">P-4</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">GAGAGGAATTCCCAGCTATTA</em>\n</td><td align="left" rowspan="1" colspan="1">1428&#x02013;1448</td></tr><tr><td align="left" rowspan="1" colspan="1">M-1</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">ATGGAATATTCTTACAAACAA</em>\n</td><td align="left" rowspan="1" colspan="1">633&#x02013;653</td></tr><tr><td align="left" rowspan="1" colspan="1">M-2</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">AAGCTTCAGTATAAATGTGTA</em>\n</td><td align="left" rowspan="1" colspan="1">337&#x02013;357</td></tr><tr><td align="left" rowspan="1" colspan="1">M-3</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">ATGGAACAGCTCGATGGATTA</em>\n</td><td align="left" rowspan="1" colspan="1">201&#x02013;221</td></tr><tr><td align="left" rowspan="1" colspan="1">M-4</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CAACACATGGCTGATTTCTAA</em>\n</td><td align="left" rowspan="1" colspan="1">801&#x02013;821</td></tr><tr><td align="left" rowspan="1" colspan="1">M-5</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CCCGGTCAATTTCCGAGACGA</em>\n</td><td align="left" rowspan="1" colspan="1">723&#x02013;743</td></tr><tr><td align="left" rowspan="1" colspan="1">M-6</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">TGCGATCAATCCATTCAGAGA</em>\n</td><td align="left" rowspan="1" colspan="1">369&#x02013;389</td></tr><tr><td align="left" rowspan="1" colspan="1">M-7</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CAGTGGATACATTGGGAAGAA</em>\n</td><td align="left" rowspan="1" colspan="1">435&#x02013;455</td></tr><tr><td align="left" rowspan="1" colspan="1">M-8</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">TCCATGATGTTTGTCCCAGAA</em>\n</td><td align="left" rowspan="1" colspan="1">598&#x02013;618</td></tr></tbody></table></div><div id="largeobj_idm139859959125696" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/table/pone-0008615-t001/?report=objectonly">Open in a separate window</a></div></div><p id="__p13" class="p">(<a href="http://www1.qiagen.com/Products/GeneSilencing/SiRnaDuplexes/HPGuaranteed.aspx" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www1.qiagen.com/Products/GeneSilencing/SiRnaDuplexes/HPGuaranteed.aspx</a>).</p></div><div id="s2d" class="sec"><h3 id="s2dtitle">Transfection of siRNA</h3><p id="__p15" class="p p-first-last">For the transfection of siRNA, amaxa nucleofactor II device and supplemented kit V solution was used as suggested by the manufacturer. For transfection using HiPerfect reagent, HEK-293 cells were seeded 12&#x02013;16 hr before transfection in a six-well plate (1&#x000d7;10<sup>5</sup> per well). Lipid-siRNA complexes were prepared by incubating 100 pmol of siRNA with HiPerfect reagent (QIAGEN, Valencia, CA) in the appropriate volume as recommended by the manufacturer. To determine transfection efficiency, P-2 siRNA tagged with Alexa Fluor-647 was used (Qiagen, Valencia, CA).</p></div><div id="s2e" class="sec"><h3 id="s2etitle">P gene siRNA validation with pAcGFP1N1-CHPV-P</h3><p id="__p16" class="p p-first-last">Cells were transfected with P gene siRNA (P-1 to P-4) at a concentration of 100 pmol and 2 &#x000b5;g of target expressing plasmid pAcGFP1N1-CHPV-P. 24 hr post transfection, cells were harvested and flow cytometry and real time one step RT-PCR were carried out. For real time one step RT-PCR, RNA was isolated using RNAeasy minikit (QIAGEN, Valencia, CA) as described by the manufacturer. To remove plasmid 80U RNase-free DNase&#x02122; (Promega, Madison, USA) enzyme was used. 500 ng of total RNA was used for real time one step RT-PCR. Each real time one step RT-PCR assay had at least two no amplification controls (NAC) in which RT enzyme was substituted by DNase-RNase free water to check for the DNA contamination.</p></div><div id="s2f" class="sec"><h3 id="s2ftitle">P gene and M gene validation with CHPV</h3><p id="__p17" class="p p-first-last">HEK-293 cells were infected with 360 plaque forming units (PFU) of CHPV. Cells were transfected with 100 pmol of different siRNAs at 2 hr PI. Cell supernatants were harvested 24 hr post transfection, RNA isolated using QIAmp viral RNA minikit (QIAGEN, Valencia, CA) and real time one step RT-PCR was carried out as described earlier <a href="#pone.0008615-Kumar2" rid="pone.0008615-Kumar2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947063">[24]</a>.</p></div><div id="s2g" class="sec"><h3 id="s2gtitle">Effect of combination of siRNA on the replication of CHPV</h3><p id="__p18" class="p p-first-last">To determine the effect of combination of siRNAs on the replication of CHPV, a concentration of 100 pmol of all the siRNAs was used alone or in different combinations.</p></div><div id="s2h" class="sec"><h3 id="s2htitle">Real time one step RT-PCR, flowcytometry and plaque assay to assess gene silencing</h3><p id="__p19" class="p p-first">Total RNA from cells transfected with pAcGFP1N1-CHPV-P, mouse brain samples and viral RNA from supernatant of CHPV infected cells were subjected to real time one step RT-PCR as described earlier <a href="#pone.0008615-Kumar2" rid="pone.0008615-Kumar2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947069">[24]</a>.</p><p id="__p20">For flowcytometry acquisitions were done using FACScalibur (BD Bioscience) and analyses were performed using cell quest software (BD Bioscience).</p><p id="__p21" class="p p-last">For plaque assay Vero cells were grown to near confluence in 24-well tissue culture plate. The cells were adsorbed with 10-fold serially diluted supernatant containing CHPV at 37&#x000b0;C for 60 min. Following adsorption, the cells were washed with PBS and fed with 1 ml of 2X MEM (Sigma, USA) along with 1.25&#x00025; (w/v) carboxymethyl cellulose (Sigma, USA). The cells were incubated for 2 days and observed for plaques under an inverted microscope and stained with crystal violet (0.1&#x00025;) after fixing in 10&#x00025; (v/v) formal saline. The plaques were counted and the titer of the virus was calculated as PFU/ml <a href="#pone.0008615-Reed1" rid="pone.0008615-Reed1" class=" bibr popnode">[25]</a>.</p></div><div id="s2i" class="sec"><h3 id="s2ititle">Tolerance for mismatches</h3><p id="__p22" class="p p-first-last">To investigate the tolerance of RNAi system for mismatches in the siRNA relative to target mRNA, different siRNAs with mismatches at specific positions as shown in <a href="/pmc/articles/PMC2797643/table/pone-0008615-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0008615-t002" rid-ob="ob-pone-0008615-t002" co-legend-rid=""><span>Table 2</span></a> and <a href="/pmc/articles/PMC2797643/figure/pone-0008615-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g001" rid-ob="ob-pone-0008615-g001" co-legend-rid="lgnd_pone-0008615-g001"><span>Fig 1</span></a> were designed.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0008615-t002"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Mutant siRNAs used for determining tolerance of mismatches in the P-2 siRNA.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139860037849104" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">S. No</td><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Nucleotide</td><td align="left" rowspan="1" colspan="1">Target sequence (Change is shown in Bold)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1.</td><td align="left" rowspan="1" colspan="1">P-2 (7)</td><td align="left" rowspan="1" colspan="1">(<em class="gene">A --<strong>T</strong>\n</em>)</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CGAATC<strong>T</strong>CCTGGCTCCAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">2.</td><td align="left" rowspan="1" colspan="1">P-2 (8)</td><td align="left" rowspan="1" colspan="1">(<em class="gene">C--<strong>G</strong>\n</em>)</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CGAATCA<strong>G</strong>CTGGCTCCAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">3.</td><td align="left" rowspan="1" colspan="1">P-2 (9)</td><td align="left" rowspan="1" colspan="1">(<em class="gene">C--<strong>G</strong>\n</em>)</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CGAATCAC<strong>G</strong>TGGCTCCAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">4.</td><td align="left" rowspan="1" colspan="1">P-2 (10)</td><td align="left" rowspan="1" colspan="1">(<em class="gene">T--<strong>A</strong>\n</em>)</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CGAATCACC<strong>A</strong>GGCTCCAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">5.</td><td align="left" rowspan="1" colspan="1">P-2 (7&#x02013;8)</td><td align="left" rowspan="1" colspan="1">(<em class="gene">AC-<strong>TG</strong>\n</em>)</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CGAATC<strong>TG</strong>CTGGCTCCAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">6.</td><td align="left" rowspan="1" colspan="1">P-2 (9&#x02013;10)</td><td align="left" rowspan="1" colspan="1">(<em class="gene">CT-<strong>GA</strong>\n</em>)</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CGAATCAC<strong>GA</strong>GGCTCCAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">7.</td><td align="left" rowspan="1" colspan="1">P-2 (7&#x02013;10)</td><td align="left" rowspan="1" colspan="1">(<em class="gene">ACCT-<strong>GTTC</strong>\n</em>)</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">CGAATC<strong>GTTC</strong>GGCTCCAAA</em>\n</td></tr></tbody></table></div><div id="largeobj_idm139860037849104" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/table/pone-0008615-t002/?report=objectonly">Open in a separate window</a></div></div></div><div id="s2j" class="sec"><h3 id="s2jtitle">Comparison of P-2 siRNA and P-2 short hairpin RNA (shRNA) efficiency</h3><p id="__p23" class="p p-first">To deliver the siRNA in shRNA format and to compare efficiency of the siRNA and shRNA, the sequence of the P-2 siRNA was subjected to the link <a href="http://www.ambion.com/techlib/misc/psilencer_converter.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.ambion.com/techlib/misc/psilencer_converter.html</a>. DNA oligos were synthesized and named as pH1-P2 or pCMV-P2 depending upon the plasmid promoter used for the expression of shRNA. Following a report documenting hypersusceptibility of Dicer-1-deficient mice to VSV infection as a result of impaired miR-24 and miR-93 expression <a href="#pone.0008615-Otsuka1" rid="pone.0008615-Otsuka1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809907">[26]</a>, we examined the contribution of miR-93 in the replication of CHPV. Use of bioinformatics tools, RNA22 (<a href="http://cbcsrv.watson.ibm.com/rna22_targets.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://cbcsrv.watson.ibm.com/rna22_targets.html</a>) and RNAhybrid (<a href="http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/submission.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/submission.html</a>) revealed that CHPV P gene has two potential binding site for hsa-miR-93. After confirmation, the role of miR-93 in the CHPV replication was assessed by using the stem and loop of miR-93 in different combinations using pSilencer 2.0 H1 neo vector (Ambion, Applied Biosystems International, Foster City, CA) and named pH1-mir-93 (hsa-miR-93 precursor sequence), pH1-miR-93-P-2 (stem of miR-93 was replaced with P-2 siRNA) and pH1-mir-93-P-2-30 (stem and loop of miR-93 was replaced with P-2 siRNA and miR-30 respectively) was used. All the oligos were synthesized by IDT, USA (<a href="/pmc/articles/PMC2797643/table/pone-0008615-t003/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0008615-t003" rid-ob="ob-pone-0008615-t003" co-legend-rid=""><span>Table 3</span></a>). Sense and antisense oligos were annealed and ligated to either pSilencer 3.1 H1 neo or pSilencer 4.1 CMV neo vectors (Ambion, Applied Biosystems International, Foster City, CA) as recommended by the manufacturer. All the clones were screened by restriction digestion and confirmed by sequencing. Endofree maxi preps were made and quantitated. Different shRNA expressing plasmids (5 &#x000b5;g) were co-transfected individually with plasmid pAcGFP1N1-CHPV-P (500 ng). 24 hr post transfection, cells were harvested, RNA isolated and real time one step RT-PCR and FACS analysis were carried out. Different shRNA expressing plasmids were individually transfected 24 hr at post transfection, cells were infected with 36 PFU/ml of CHPV. At 12 and 24 hr post PI, supernatants were assayed for the presence of the CHPV by plaque assay and real time one step RT-PCR.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0008615-t003"><h3>Table 3</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Sequences of the shRNA oligos used.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139859968717344" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">S No</td><td align="left" rowspan="1" colspan="1">Name of the oligo</td><td align="left" rowspan="1" colspan="1">Sequences of the oligo</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">pH1-P2 sense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">GATCCGCGAATCACCTGGCTCCAAATTCAAGAGATTTGGAGCCAGGTGATTCGGTTTTTTTGGAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">pH1-P2 antisense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">AGCTTTTCCAAAAAAACCGAATCACCTGGCTCCAAATCTCTTGAGTTTGGAGCCAGGTGATTCGCG</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">pCMV-P2 sense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">GATCCCGAATCACCTGGCTCCAAATTCAAGAGATTTGGAGCCAGGTGATTCGGTA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">pCMV-P2 antisense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">AGCTTACCGAATCACCTGGCTCCAAATCTCTTGAATTTGGAGCCAGGTGATTCGG</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">pH1-miR-93 sense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">GATCCGCTGGGGGCTCCAAAGTGCTGTTCGTGCAGGTAGTGTGATTACCCAACCTACTGCTGAGCTAGCACTTCCCGAGCCCCGGTTTTTGGAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">pH1-miR-93 antisense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">AGCTTTTCCAAAAAACCGGGGGCTCGGGAAGTGCTAGCTCAGCAGTAGGTTGGGTAATCACACTACCTGCACGAACAGCACTTTGGAGCCCCCAGCG</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">pH1-miR-93-P-2 sense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">GATCCGCTGGGGGCTCCAGCGAATCACCTGGCTCCAAATGTGATTACCCAACTTTGGAGCCAGGTGATTCGCCCCGAGCCCCCGGTTTTTTGGAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">pH1-miR-93-P-2 antisense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">AGCTTTTCCAAAAAACCGGGGGCTCGGGGCGAATCACCTGGCTCCAAACTTGGGTAATCACATTTGGAGCCAGGTGATTCGCTGGAGCCCCCAGCG</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">pH1-miR-93-P-2-30 sense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">GATCCGCTGGGGGCTCCAGCGAATCACCTGGCTCCAAATGTGGTGAAGCCACAGATGCAACTTTGGAGCCAGGTGATTCGCCCCGAGCCCCCGGTTTTTTGGAAA</em>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">H1-miR-93-P-2-30 antisense</td><td align="left" rowspan="1" colspan="1">\n<em class="gene">AGCTTTTCCAAAAAACCGGGGGCTCGGGGCGAATCACCTGGCTCCAAAGTTGCATCTGTGGCTTCACCACATTTGGAGCCAGGTGATTCGCTGGAGCCCCAGCC</em>\n</td></tr></tbody></table></div><div id="largeobj_idm139859968717344" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/table/pone-0008615-t003/?report=objectonly">Open in a separate window</a></div></div></div><div id="s2k" class="sec"><h3 id="s2ktitle">Mouse infection</h3><p id="__p24" class="p p-first-last">BALB/c mice aged 4&#x02013;6 wks were used for all <em>in vivo</em> experiments. These experiments were done in a biosafety level 2 animal facility at the NIV and were approved by the Institutional Animal Ethics Committee (IAEC) for animal experimentations. Mice were inoculated intracranially (ic) with CHPV. For experiments using siRNA, siRNAs were complexed with HiPerfect&#x02122; (QIAGEN, Valencia CA) according to the manufacturer\'s instructions and were administered at the same site once simultaneously or at different intervals.</p></div><div id="s2l" class="sec"><h3 id="s2ltitle">Mouse tissue preparation for real time one step RT-PCR, gene expression and histopathology</h3><p id="__p25" class="p p-first">Mice (n&#x0200a;=&#x0200a;3) were euthanized and brains/spleens were removed and used in various experiments. For histopathology, the brain samples were fixed in 10&#x00025; neutral buffered formalin, embedded in paraffin and 6-&#x000b5;m vertical sections were stained with hematoxylin and eosin. For the quantitative assessment of CHPV replication in mice brain using real time one step RT-PCR, RNA isolated using Ribopure RNA isolation Kit (Ambion, USA) according to manufacturer\'s instructions and 500 ng of total RNA was used per reaction <a href="#pone.0008615-Kumar2" rid="pone.0008615-Kumar2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947072">[24]</a>.</p><p id="__p26" class="p p-last">Gene expression analysis using TaqMan Low Density Array (TLDA), single-cell suspension of spleens were prepared by gently teasing in RPMI medium and RNA isolated as above. RNA from spleens of the mice (n&#x0200a;=&#x0200a;3) from same group were pooled and samples were run in duplicate on 7900-HT fast real time PCR machine (Applied Biosystems International, Foster City, CA). Data analysis was done using RQ software, with respect to control (uninfected/untreated) and HPRT was used as endogenous control.</p></div><div id="s2m" class="sec sec-last"><h3 id="s2mtitle">Statistical analysis</h3><p id="__p27" class="p p-first-last">Statistical analyses were done using XLSTAT 2009 program in Excel 2007 software. Three independent experiments were performed in triplicates. Results are expressed as means &#x000b1; SD. Data were analyzed by one way ANOVA followed by Dunnett\'s test. For <em>in vivo</em> experiments, mice survivals were compared using Log-rank (Mental Cox) and Gehan-Breslow-Wilcoxon tests and GraphPad Prism software 5.0 evaluation version.</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Results</h2><div id="s3a" class="sec sec-first"><h3 id="s3atitle">Expression of P gene fused with GFP</h3><p id="__p28" class="p p-first-last">For the initial rapid and efficient assessment of gene silencing, P gene of CHPV was expressed with GFP as fusion protein. Fluorescent microscopy and Western blotting confirmed expression of P protein fused with GFP. The molecular weight of the fusion protein was approximately &#x0223c;61.0 Kda. The molecular weight of the GFP protein is 29.0 Kda and the molecular weight of bacterial expressed P protein is 32.5 Kda <a href="#pone.0008615-Chattopadhyay1" rid="pone.0008615-Chattopadhyay1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809879">[27]</a>. Confocal microscopy of HEK-293 cells transfected with pAcGFP1N1 and pAcGFP1N1-CHPV-P showed cytoplasmic localization of fusion protein</p></div><div id="s3b" class="sec"><h3 id="s3btitle">P gene siRNA validation with pAcGFP1N1-CHPV-P and CHPV</h3><p id="__p29" class="p p-first">At 24 hr post transfection, cells transfected with both P gene siRNAs (P-1 to P-4) and target expressing plasmid pAcGFP1N1-CHPV-P showed that P-2 siRNA could reduce the GFP expression and P gene expression approximately by 80&#x00025; (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g002" rid-ob="ob-pone-0008615-g002" co-legend-rid="lgnd_pone-0008615-g002"><span>Fig 2a-c</span></a> c) (p&#x0003c;0.05), whereas P-1, P-3 and P-4 were not very effective. With respect to CHPV, efficacy of P-2 siRNA in reducing replication was 2logs at 24 hr and 1log at 48hr (p&#x0003c;0.05) as evidenced by plaque assay and real time one step RT-PCR (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g002" rid-ob="ob-pone-0008615-g002" co-legend-rid="lgnd_pone-0008615-g002"><span>Fig 2d</span></a>). A dose response experiment using 10&#x02013;300 pmol of P-2 siRNA and pAcGFP1N1-CHPV-P showed 100 pmol as optimum concentration (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g002" rid-ob="ob-pone-0008615-g002" co-legend-rid="lgnd_pone-0008615-g002"><span>Fig 2e</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g002" co-legend-rid="lgnd_pone-0008615-g002"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g002/" target="figure" rid-figpopup="pone-0008615-g002" rid-ob="ob-pone-0008615-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139859958735024" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g002.jpg" /></a></div><div id="largeobj_idm139859958735024" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g002"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g002/" target="figure" rid-figpopup="pone-0008615-g002" rid-ob="ob-pone-0008615-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Validation of P gene siRNA using pAcGFP1N1-CHPV-P.</strong><p id="__p30">(<strong>a</strong>) Fluorescent microscopic images of HEK-293 cells transfected with different P gene siRNAs and plasmid pAcGFP1N1-CHPV-P. (<strong>b</strong>) P gene siRNAs validated by flowcytometry at the protein level (<strong>c</strong>) Reduced expression of P gene mRNA by real time one step RT-PCR. (<strong>d</strong>) P gene validation with CHPV at different time points. (<strong>e</strong>) Effect of different doses of P-2 siRNA on the expression of P gene as determined by flowcytometry and real time one step RT-PCR. Result are expressed as means &#x000b1; SD. &#x0002a; indicates significantly different from control at p &#x0003c;0.05 by Dunnett\'s test.</p></div></div></div></div><div id="s3c" class="sec"><h3 id="s3ctitle">Validation of M gene siRNAs with virus and comparison with P-2 siRNA</h3><p id="__p31" class="p p-first">M gene siRNAs (M1-M8) were tested with the virus and efficiencies were compared with P-2 siRNA. The results showed P-2, M-5 and M-6 to be equally potent in inhibiting CHPV induced cytopathic effects as observed by phase-contrast microscopy (10X magnification) (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g003" rid-ob="ob-pone-0008615-g003" co-legend-rid="lgnd_pone-0008615-g003"><span>Fig 3a</span></a>). Assessment of virus replication by plaque assay and real time one step RT-PCR showed inhibition of CHPV by 2logs and thus confirmed efficacy of all the three siRNAs (p&#x0003c;0.05) (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g003" rid-ob="ob-pone-0008615-g003" co-legend-rid="lgnd_pone-0008615-g003"><span>Fig 3b</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g003" co-legend-rid="lgnd_pone-0008615-g003"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g003/" target="figure" rid-figpopup="pone-0008615-g003" rid-ob="ob-pone-0008615-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139860003942992" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g003.jpg" /></a></div><div id="largeobj_idm139860003942992" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g003"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g003/" target="figure" rid-figpopup="pone-0008615-g003" rid-ob="ob-pone-0008615-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Validation of P-2 and M gene siRNA with CHPV.</strong><p id="__p32">(<strong>a</strong>) Inhibition of CHPV induced cytopathic effects by siRNAs as observed by phase-contrast microscopy (10X). (<strong>b</strong>) Effect of different siRNAs on the replication of CHPV as determined by real time one step RT-PCR and plaque assay.Results are expressed as means &#x000b1; SD. &#x0002a; indicates significantly different from control at p&#x0003c;0.05 by Dunnett\'s test.</p></div></div></div></div><div id="s3d" class="sec"><h3 id="s3dtitle">Effect of combination of siRNAs on the replication of CHPV</h3><p id="__p33" class="p p-first">Initially, we tried combinations of P-2, M-5 and M-6 siRNAs at different concentrations (10, 25, 50, 100 and 200pmol of each siRNA) against 36, 18 and 3.6 PFU/ml. Cells could not be infected below 18PFU and no inhibition was observed at 10 and 25pmol concentrations of siRNAs. At 50 pmol, 1log and at 100 and 200pmol optimum reduction (2logs) was achieved. <a href="/pmc/articles/PMC2797643/figure/pone-0008615-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g004" rid-ob="ob-pone-0008615-g004" co-legend-rid="lgnd_pone-0008615-g004"><span>Figure 4</span></a> depicts efficiency of P-2, M-5 and M-6 siRNAs when used alone or in different combinations (P-2&#x0002b;M-5; P-2&#x0002b;M-6 and P-2&#x0002b;M-5&#x0002b;M6) at 100pmol of each siRNA. In each case,. 2logs reduction in viral titer as compared to controls was recorded (p&#x0003c;0.05). Infection with CHPV at as low as 36 PFU/ml and as high as 3600 PFU/ml did not alter the efficiency of the siRNA the reduction being 2logs in all cases (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g004" rid-ob="ob-pone-0008615-g004" co-legend-rid="lgnd_pone-0008615-g004"><span>Fig 4a-4c</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g004" co-legend-rid="lgnd_pone-0008615-g004"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g004/" target="figure" rid-figpopup="pone-0008615-g004" rid-ob="ob-pone-0008615-g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139860040159024" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g004.jpg" /></a></div><div id="largeobj_idm139860040159024" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g004"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g004/" target="figure" rid-figpopup="pone-0008615-g004" rid-ob="ob-pone-0008615-g004">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effect of P-2, M-5 and M-6 siRNAs on the replication of CHPV.</strong><p id="__p34">(<strong>a</strong>) The virus inoculum was 36 PFU/ml, (<strong>b</strong>) 360 PFU/ml and (<strong>c</strong>) 3600 PFU/ml. Results are expressed as means &#x000b1; SD. &#x0002a; indicates significantly different from control at p&#x0003c;0.05 by Dunnett\'s test.</p></div></div></div></div><div id="s3e" class="sec"><h3 id="s3etitle">Tolerance for mismatches</h3><p id="__p35" class="p p-first">P-2 siRNA could tolerate mismatches at single nucleotide (positions 7, 8, 9 and 10) two adjacent mutations (at 7&#x02013;8 and 9&#x02013;10) or four consecutive positions (at 7&#x02013;10) as judged by both pAcGFP1N1-CHPV-P and CHPV. Results showed at least 50&#x00025; P gene silencing (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g005" rid-ob="ob-pone-0008615-g005" co-legend-rid="lgnd_pone-0008615-g005"><span>Fig 5a</span></a>) (p&#x0003c;0.05) and 1log difference in the titter of CHPV in mutant siRNA treated and control cells (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g005" rid-ob="ob-pone-0008615-g005" co-legend-rid="lgnd_pone-0008615-g005"><span>Fig 5b</span></a>) (p&#x0003c;0.05).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g005" co-legend-rid="lgnd_pone-0008615-g005"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g005/" target="figure" rid-figpopup="pone-0008615-g005" rid-ob="ob-pone-0008615-g005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139860040150784" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g005.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g005.jpg" /></a></div><div id="largeobj_idm139860040150784" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g005"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g005/" target="figure" rid-figpopup="pone-0008615-g005" rid-ob="ob-pone-0008615-g005">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Tolerance of RNAi for mismatches in the P-2 siRNA relative to target mRNA.</strong><p id="__p36">Tested <em>in vitro</em> by using (<strong>a</strong>) pAcGFP1N1-CHPV-P plasmid and (<strong>b</strong>) CHPV. Results are expressed as means &#x000b1; SD. &#x0002a; indicates significantly different from control at p&#x0003c;0.05 by Dunnett\'s test.</p></div></div></div></div><div id="s3f" class="sec"><h3 id="s3ftitle">Short hairpin RNA (shRNA) validation with pAcGPF1N1-CHPV-P plasmid and with CHPV</h3><p id="__p37" class="p p-first">Flowcytometery and real time one step RT-PCR documented that P-2 shRNA expressed either from Pol III (pH1-P2) or Pol II promoter (pCMV-P2) was as efficient as P-2 siRNA, when the validation was done with pAcGFP1N1-CHPV-P. The reduction was approximately 70&#x00025; (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g006" rid-ob="ob-pone-0008615-g006" co-legend-rid="lgnd_pone-0008615-g006"><span>Fig 6a</span></a>) (p&#x0003c;0.05).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g006" co-legend-rid="lgnd_pone-0008615-g006"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g006/" target="figure" rid-figpopup="pone-0008615-g006" rid-ob="ob-pone-0008615-g006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139859967176752" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g006.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g006.jpg" /></a></div><div id="largeobj_idm139859967176752" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g006"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g006/" target="figure" rid-figpopup="pone-0008615-g006" rid-ob="ob-pone-0008615-g006">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Validation and comparison of efficiency of P-2 siRNA with different P-2 shRNA.</strong><p id="__p38">(<strong>a</strong>) Validation of different shRNA expressing plasmids with pAcGFP1N1-CHPV-P by using FACS and real time one step RT-PCR and (<strong>b</strong>) Efficiency of different shRNA expressing plasmids in modulating CHPV replication at 12hr and at 24hr determined by real time one step RT-PCR and plaque assay. Results are expressed as means &#x000b1; SD. &#x0002a; indicates significantly different from control at p&#x0003c;0.05 by Dunnett\'s test.</p></div></div></div><p id="__p39" class="p p-last">The silencing effect lasted till 12hr (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g006" rid-ob="ob-pone-0008615-g006" co-legend-rid="lgnd_pone-0008615-g006"><span>Fig 6b</span></a>) (p&#x0003c;0.05) and was lost at 24hr when tested with CHPV. At 24hr there was no difference in the treated and control cells. P-2 siRNA was used as a positive control and showed activity similar to experiments conducted earlier.</p></div><div id="s3g" class="sec sec-last"><h3 id="s3gtitle">Effect of intracranial administration of P-2 siRNA on CHPV infection in mice</h3><p id="__p40" class="p p-first">Transfection efficiencies of Alexa fluor-647nm-labeled P-2 siRNA either with nucleofaction or Hiperfect reagent in HEK-293 cells were 83 and 62&#x00025; respectively, as measured by flowcytometry. When the cells infected with 360 pfu/ml CHPV were treated with P-2 siRNA, Hiperfect was less effective than nucleofaction (2logs reduction at 12hr for both and 1log less at 24hr). For all in-vivo experiments Hiperfect reagent was used for delivery of P-2 siRNA. As adult mice are not susceptible to CHPV by peripheral route, intracranial route was used for infection with the virus.</p><p id="__p41">For the first experiment, 100LD<sub>50</sub> CHPV was used. Simultaneous treatment either with P-2 siRNA (5 &#x000b5;g) or ncsiRNA (5 &#x000b5;g) complexed with Hiperfect at the same site led to survival of 5&#x02013;7 days in former and 4&#x02013;5 days in latter groups (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g007" rid-ob="ob-pone-0008615-g007" co-legend-rid="lgnd_pone-0008615-g007"><span>Fig 7a</span></a>) (p&#x0003c;0.006).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g007" co-legend-rid="lgnd_pone-0008615-g007"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g007/" target="figure" rid-figpopup="pone-0008615-g007" rid-ob="ob-pone-0008615-g007"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139859964919008" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g007.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g007.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g007.jpg" /></a></div><div id="largeobj_idm139859964919008" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g007/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g007"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g007/" target="figure" rid-figpopup="pone-0008615-g007" rid-ob="ob-pone-0008615-g007">Figure 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Kaplan Meier Survival curve showing effect of different doses of virus and siRNA.</strong><p id="__p42">(<strong>a</strong>) 100LD<sub>50</sub> CHPV and single dose of P-2 siRNA was administered (n&#x0200a;=&#x0200a;5) (p&#x0003c;0.006). (<strong>b</strong>) 10 LD<sub>50</sub> of CHPV and single or two doses (n&#x0200a;=&#x0200a;10 for both) of P-2 siRNA (p&#x0003c;0.0001).</p></div></div></div><p id="__p43">In another experiment, the virus dose was reduced to 10 LD<sub>50.</sub> Mice received one (simultaneous) or two doses (0 and 24hr) of 5 ug P-2 siRNA. In the first group, the animals showed extended survival by 48 hr (&#x0223c;60&#x00025; mice) followed by survival of one mouse (10&#x00025;, (p&#x0003c;0.001). Importantly, &#x0223c;70&#x00025; survival was recorded in mice receiving two doses of P-2 siRNA (p&#x0003c;0.0001) (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g007" rid-ob="ob-pone-0008615-g007" co-legend-rid="lgnd_pone-0008615-g007"><span>Fig 7b</span></a>). In accordance with the extended survival, the viral titres in the brain tissue from mice treated with two doses of P-2 siRNA were reduced by 4logs as compared to the control group (p&#x0003c;0.00031) (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g008/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g008" rid-ob="ob-pone-0008615-g008" co-legend-rid="lgnd_pone-0008615-g008"><span>Fig 8</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g008" co-legend-rid="lgnd_pone-0008615-g008"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g008/" target="figure" rid-figpopup="pone-0008615-g008" rid-ob="ob-pone-0008615-g008"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139859966461968" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g008.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g008.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g008.jpg" /></a></div><div id="largeobj_idm139859966461968" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g008/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g008"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g008/" target="figure" rid-figpopup="pone-0008615-g008" rid-ob="ob-pone-0008615-g008">Figure 8</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Reduction in the levels of CHPV replication in mice brain.</strong><p id="__p44">Each day, brain homogenates from 3 mice were taken for RNA isolation and used for real time RT-PCR. Each symbol represents individual mouse. Data are shown only till all mice in control group died.</p></div></div></div><p id="__p45">Histopathology of the brains of ncsiRNA treated mice showed typical features of viral encephalitis, such as meningeal vessels with perivascular cuffing of lymphocytes (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g009/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g009" rid-ob="ob-pone-0008615-g009" co-legend-rid="lgnd_pone-0008615-g009"><span>Fig 9a</span></a>) and focus of gliosis &#x00026; demyelination in cortex (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g009/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g009" rid-ob="ob-pone-0008615-g009" co-legend-rid="lgnd_pone-0008615-g009"><span>Fig 9b</span></a>). Absence of brain inflammation or neuropathology was obvious in P-2 siRNA-treated mice (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g009/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g009" rid-ob="ob-pone-0008615-g009" co-legend-rid="lgnd_pone-0008615-g009"><span>Fig 9c and 9d</span></a>). Both mice groups were sacrificed on 5<sup>th</sup> day post-CHPV inoculation.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g009" co-legend-rid="lgnd_pone-0008615-g009"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g009/" target="figure" rid-figpopup="pone-0008615-g009" rid-ob="ob-pone-0008615-g009"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139860000990224" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g009.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g009.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g009.jpg" /></a></div><div id="largeobj_idm139860000990224" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g009/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g009"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g009/" target="figure" rid-figpopup="pone-0008615-g009" rid-ob="ob-pone-0008615-g009">Figure 9</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Histopathology of mice brain treated with P-2 siRNA.</strong><p id="__p46">Hematoxylin and eosin-stained vertical brain sections from control mice treated with ncsiRNA and infected with CHPV (<strong>a, b</strong>) and P-2 siRNA treated mice on 5<sup>th</sup> day PI (<strong>c, d</strong>) at indicated magnifications.</p></div></div></div><p id="__p47">In order to rule out the induction of non-specific interferon responses by P-2 siRNA, TLDA was performed. Gene expression changes &#x02265;2.5 fold were considered significant. Expression of IFN-&#x003b3; (&#x0003e;100-fold), IL-10 (&#x0223c;17fold), IL-1&#x003b2; (2.8 fold), IL-15 (&#x0223c;8-fold), SOCS-1(&#x0223c;17-fold) and TNF (&#x0223c;5-fold) cytokines genes were upregulated at 24hr PI. A significant reduction in the expression of IFN-&#x003b3; (&#x0223c;2.5-fold) was noted at 48 and 96hr PI. IL-10 (&#x0223c;2.3-fold) decreased at 48hr but increased at 96hr (6-fold) while SOCS-1 decreased at all the time points (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g010/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g010" rid-ob="ob-pone-0008615-g010" co-legend-rid="lgnd_pone-0008615-g010"><span>Fig 10a</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g010" co-legend-rid="lgnd_pone-0008615-g010"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g010/" target="figure" rid-figpopup="pone-0008615-g010" rid-ob="ob-pone-0008615-g010"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139859957076256" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g010.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g010.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g010.jpg" /></a></div><div id="largeobj_idm139859957076256" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g010/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g010"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g010/" target="figure" rid-figpopup="pone-0008615-g010" rid-ob="ob-pone-0008615-g010">Figure 10</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Gene expression profiles of siRNA treated mice using TLDA.</strong><p id="__p48">(<strong>a</strong>) cytokines genes, (<strong>b</strong>) chemokine genes and (<strong>c</strong>) cell surface molecules in spleen of mice from 3 groups- (1) CHPV infected control (2) CHPV infected and P-2 siRNA treated and (3) Hiperfect &#x0002b; P-2 siRNA inoculated control. Results are expressed as means &#x000b1; SD.</p></div></div></div><p id="__p49">Expression of the chemokines genes (Ccl-2, &#x0003e;200-fold; csf2, &#x0003e;10-fold and Ccxl-10, &#x0223c;30-fold) and surface receptor molecules (FasL, &#x0003e;2.5 fold and IL-2R, 4-fold) were upregulated at the initial phase of infection, but decreased at later time points (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g010/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g010" rid-ob="ob-pone-0008615-g010" co-legend-rid="lgnd_pone-0008615-g010"><span>Fig 10b, c</span></a>). None of the above changes observed in CHPV infected mice were recorded in mice treated with P-2 siRNA or control mice receiving P-2 siRNA complexed with Hiperfect. These data clearly show that the protection offered by P-2 siRNA is specific and does not reflect non-specific anti-viral response of IFN.</p><p id="__p50">Anti-CHP-IgG antibodies were absent on days 7, 14 and 21 post-infection in P-2 siRNA treated, surviving mice.</p><p id="__p51" class="p">Considering therapeutic importance, ability of P-2 siRNA to clear established CHPV infection was also evaluated. Two doses of siRNA (5 &#x000b5;g each 24hr apart) were found to give 40&#x00025; and 20&#x00025; protection respectively when the treatment was given 2hr and 4hr post-infection (p&#x0003c;0.0001) (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g011/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g011" rid-ob="ob-pone-0008615-g011" co-legend-rid="lgnd_pone-0008615-g011"><span>Fig 11a, b</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0008615-g011" co-legend-rid="lgnd_pone-0008615-g011"><a href="/pmc/articles/PMC2797643/figure/pone-0008615-g011/" target="figure" rid-figpopup="pone-0008615-g011" rid-ob="ob-pone-0008615-g011"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139859966268976" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2797643_pone.0008615.g011.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0008615.g011.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2797643/bin/pone.0008615.g011.jpg" /></a></div><div id="largeobj_idm139859966268976" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2797643/figure/pone-0008615-g011/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0008615-g011"><div><a class="figpopup" href="/pmc/articles/PMC2797643/figure/pone-0008615-g011/" target="figure" rid-figpopup="pone-0008615-g011" rid-ob="ob-pone-0008615-g011">Figure 11</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Kaplan Meier Survival curve showing efficiency of P-2 siRNA in clearing established CHPV replication.</strong><p id="__p52">When administered (<strong>a</strong>) 2hr and (p&#x0003c;0.0001) (<strong>b</strong>) 4hr post virus inoculation (p&#x0003c;0.0001). In both cases the second siRNA dose was given at 24hr post infection.</p></div></div></div></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Discussion</h2><p id="__p53" class="p p-first">Following the recognition of emergence of CHPV as an emerging pathogen causing rapid and high mortality in children in India, being the national institute and considering restricted spread of the virus, we undertook two approaches as probable strategies to combat the infection, development of a prophylactic vaccine <a href="#pone.0008615-Venkateswarlu1" rid="pone.0008615-Venkateswarlu1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809887">[28]</a> and siRNA administration as a probable therapeutic agent (present study). We were able to identify a potent siRNA that could protect mice from the lethal encephalitis even when the virus was directly introduced in the target organ, the brain.</p><p id="__p54">The first step was selection of the viral gene(s) to be targeted by RNAi. We selected P and M genes as (1) P protein is indispensable for the activity of L protein which functions as RNA dependent RNA polymerase (RdRp) and (2) M protein is most lethal protein encoded by rhabdoviruses on account of induction of cytopathic effects and apoptosis in the cells <a href="#pone.0008615-Licata1" rid="pone.0008615-Licata1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809876">[29]</a>.</p><p id="__p55">Initially, a total of 12 siRNAs (4 for P gene and 8 for M gene) were screened <em>in-vitro</em>. Co-transfection of pAcGFP1N1-CHPV-P plasmid and all the P gene siRNAs identified P-2 siRNA as the most potent in perturbing P gene expression (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g002" rid-ob="ob-pone-0008615-g002" co-legend-rid="lgnd_pone-0008615-g002"><span>Fig 2</span></a>). M gene siRNAs were directly validated with the virus. P-2, M-5 and M-6 siRNAs were equally efficient in inhibiting CHPV induced cytopathic effects (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g003" rid-ob="ob-pone-0008615-g003" co-legend-rid="lgnd_pone-0008615-g003"><span>Fig 3</span></a>). Replication inhibition in siRNA treated cells was also confirmed by 2logs reduction in the virus titer as evidenced by both plaque assay and real time one step RT- PCR (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g003" rid-ob="ob-pone-0008615-g003" co-legend-rid="lgnd_pone-0008615-g003"><span>Fig 3b</span></a>). Unfortunately, use of combinations of effective siRNAs at different concentrations did not yield additive benefit. A possible explanation could be that cells have a limited capacity to assemble the RNA-induced silencing complex (RISC) and siRNA\'s compete for the available RISC pool present in the cells <a href="#pone.0008615-Hutvagner1" rid="pone.0008615-Hutvagner1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809894">[30]</a>. Similar observations have been reported for two respiratory viruses, respiratory syncytial virus and parainfluenza virus <a href="#pone.0008615-Bitko1" rid="pone.0008615-Bitko1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809895">[15]</a>, <a href="#pone.0008615-Fulton1" rid="pone.0008615-Fulton1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809890">[31]</a>.</p><p id="__p56">To assess the specificity, inhibition of CHPV replication in P-2 and M-5/M-6 siRNA treated cells was assessed by G gene and P gene-based real time PCRs respectively (data not shown). In both cases, 2logs reduction was recorded. This may reflect the possibility of these siRNAs not only targeting their cognate mRNA but also the positive (&#x0002b;) strand pre-genomic RNA thus affecting overall replication of the virus.</p><p id="__p57">So far, P gene / full genomes of CHPV isolated during 1965, 2003, 2004 and 2007 have been sequenced [23, our unpublished data]. Percent nucleotide identity (PNI) for P gene varied from 99.7 to 95.8&#x00025;. Thus the virus has not changed appreciably over a period of 42 years. Despite the stable nature of the virus, tolerance of mismatches in the P-2 siRNA was examined as this molecule was to be evaluated in <em>in-vivo</em> experiments. Though mismatches in the center of the siRNA duplex are most critical abolishing target cleavage <a href="#pone.0008615-Elbashir1" rid="pone.0008615-Elbashir1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947071">[32]</a>, <a href="#pone.0008615-Brummelkamp1" rid="pone.0008615-Brummelkamp1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809874">[33]</a>, introduction of different mismatches did show inhibition of the virus, at reduced rate (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g005" rid-ob="ob-pone-0008615-g005" co-legend-rid="lgnd_pone-0008615-g005"><span>Fig 5</span></a>). Thus, even if the virus mutates, this siRNA will still be effective.</p><p id="__p58">Considering several advantages offered by shRNA such as requirement for low doses, long-term downregulation of the target gene and an economic alternative to the siRNA, we also tried the shRNA format. Though efficient silencing was observed at 12hr, the efficacy was lost at 24hr (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g006" rid-ob="ob-pone-0008615-g006" co-legend-rid="lgnd_pone-0008615-g006"><span>Fig 6b</span></a>). This could possibly be because of apoptosis and subsequent inhibition of host transcription induced by M protein for both CHPV <a href="#pone.0008615-Taylor1" rid="pone.0008615-Taylor1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809878">[34]</a> and VSV <a href="#pone.0008615-Ahmed1" rid="pone.0008615-Ahmed1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809906">[35]</a> infections. Similar to our findings, abrogation of DNA based RNAi was found in apoptotic cells due to caspace-3 mediated inactivation of Dicer-1 without affecting RISC dependent part of RNAi <a href="#pone.0008615-Ghodgaonkar1" rid="pone.0008615-Ghodgaonkar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809882">[36]</a>. Therefore, siRNA seems to be a better approach for regulating CHPV replication especially because it is an acute infection with rapid course and long-term treatment is not needed. However, in a recent study, efficacy of shRNA was effectively shown for the treatment of JEV encephalitis in mice by using lentiviral vector. 100&#x00025; survival was recorded when mice were injected IC with pseudotyped RV-G lentiviral vector expressing shRNA specific for JEV and challenged half an hour later with 4 LD<sub>50</sub> of JEV at the same site <a href="#pone.0008615-Kumar1" rid="pone.0008615-Kumar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947064">[20]</a>.</p><p id="__p59">With the encouraging <em>in-vitro</em> results, we attempted to evaluate P-2 siRNA in a murine model. Availability and selection of suitable delivery system was the key question. Although successful use of naked siRNA targeting the pain-related cation channel P2X3 to treat chronic neuropathic pain in a rat model is reported <a href="#pone.0008615-Dorn1" rid="pone.0008615-Dorn1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809903">[37]</a>, poor uptake by brain parenchymal cells was shown in other studies <a href="#pone.0008615-Isacson1" rid="pone.0008615-Isacson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809899">[38]</a>, <a href="#pone.0008615-Lingor1" rid="pone.0008615-Lingor1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809888">[39]</a>. Recently, a cationic lipid formulation, i-Fect (Neuromics) was found to deliver siRNA into neuronal cells without toxicity and could protect mice against viral encephalitis caused by flaviviruses <a href="#pone.0008615-Kumar1" rid="pone.0008615-Kumar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947062">[20]</a>. We used P-2 siRNA complexed with a cationic lipid (Hiperfect) for delivery into brain.</p><p id="__p60">Simultaneous administration of 5 &#x000b5;g P-2 siRNA and 100 or 10LD<sub>50</sub> virus resulted in 48 and 96 hr delay respectively in the appearance of symptoms and death (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g007" rid-ob="ob-pone-0008615-g007" co-legend-rid="lgnd_pone-0008615-g007"><span>Fig 7a and b</span></a>). One mouse survived with the lower dose of the virus. Importantly, when two doses 5 &#x000b5;g P-2 siRNA were administered 24 hr apart, 70&#x00025; mice survived. In this experiment, the first dose of siRNA was given simultaneously with the virus. To examine the degree of protection offered by siRNA when administered after the virus inoculation, a different two dose schedule was tried. i.e., 2 or 4 hr and 24hr-post-virus inoculation (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g011/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g011" rid-ob="ob-pone-0008615-g011" co-legend-rid="lgnd_pone-0008615-g011"><span>Fig 11a and 11b</span></a>). Survival was reduced to 40&#x00025; and 20&#x00025; respectively. Considering the rapidity of CHPV replication, these results are significant. If we could introduce large amount of siRNA post-infection, survival of mice seems likely. Due to the limitation of the volume, this could not be tried. It is pertinent to note here that for JE virus, a single injection containing 40ug of siRNA with JetSI/DOPE led to complete protection <a href="#pone.0008615-Kumar1" rid="pone.0008615-Kumar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_674947067">[20]</a>. We need to try different liposome formulations encapsulating optimum concentration of P-2 siRNA for achieving near 100&#x00025; survival when administered after infection with the virus at variable intervals.</p><p id="__p61">For the siRNA dosing yielding optimum protection (2 doses, 24hr apart) additional parameters were evaluated. Daily monitoring of CHPV titers in the brain by real time one step RT-PCR (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g008/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g008" rid-ob="ob-pone-0008615-g008" co-legend-rid="lgnd_pone-0008615-g008"><span>Fig 8</span></a>) clearly showed 4logs reduction in mice treated with P-2 siRNA when compared to ncsiRNA treated controls. Histopathological analysis demonstrated that P-2 siRNA treated mice brains did not exhibit common features of viral encephalitis seen exclusively in the control group (<a href="/pmc/articles/PMC2797643/figure/pone-0008615-g009/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g009" rid-ob="ob-pone-0008615-g009" co-legend-rid="lgnd_pone-0008615-g009"><span>Fig 9</span></a>). In order to prove that the protection offered was indeed due to siRNA, we screened sera of survived mice at 7, 14 and 21 days after infection for the presence of anti-CHP-IgG antibodies. Absence of such antibodies demonstrated limited / no viral replication leading to no development of humoral response (Data not shown).</p><p id="__p62">To generate additional information on the immune response, gene expression profiles were studied. For this, we used spleen and not brain primarily because our aim was not to dissect out effect of CHPV infection on the regulation of these genes in mice, but limited to compare the expression levels of immune response genes in among the siRNA treated and control mice receiving the same dose of the virus. In this regard a paper by Koterski <em>et al</em>\n<a href="#pone.0008615-Koterski1" rid="pone.0008615-Koterski1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809897">[40]</a> on Venazuelan equine encephalitis virus (VEEV) is noteworthy.</p><p id="__p63">IFN has been shown to have antiviral effect both against VSV <a href="#pone.0008615-Trottier1" rid="pone.0008615-Trottier1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809881">[41]</a> and CHPV <a href="#pone.0008615-Tripathy1" rid="pone.0008615-Tripathy1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809884">[42]</a> as evidenced by <em>in-vitro</em> and human studies respectively. <a href="/pmc/articles/PMC2797643/figure/pone-0008615-g010/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0008615-g010" rid-ob="ob-pone-0008615-g010" co-legend-rid="lgnd_pone-0008615-g010"><span>Fig 10a</span></a> clearly documents excessive upregulation of IFN gene in the early stages of the infection (24hr PI) followed by drastic decrease. Thus, though IFN is produced in large quantities to combat the infection, desired effect was not achieved leading to death. Importantly, no elevation was recorded in virus-infected P-2 siRNA treated as well as control mice receiving the vehicle alone. IL-10, involved in the suppression of the protective immune response was elevated in the initial phase and at the time of death. This cytokine might be playing crucial role in the pathogenesis of CHPV. The elevated expression of TNF and IL-1&#x003b2; were found to decrease with time that is consistent with a previous report documenting susceptibility of TNF-&#x003b1; and IL-1&#x003b2; knockout (KO) mice to lethal HSV-1 encephalitis <a href="#pone.0008615-Sergerie1" rid="pone.0008615-Sergerie1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809877">[43]</a>. SOCS-1, the suppressor of cytokine signaling gene playing a critical role in the negative regulation of cytokine signaling was steadily decreasing after initial elevation. These results are similar to a study with rabies virus infection wherein downregulation of SOCS-1 gene was shown <a href="#pone.0008615-Nuovo1" rid="pone.0008615-Nuovo1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809892">[44]</a>.</p><p id="__p64">The elevated levels of Ccl2 and Cxcl-10 suggest recruitment and activation of dendritic cells, macrophages, neutrophills and other white cells to the sites of infection. However, as TNF and IFN-&#x003b3; are known to induce Cxcl-10, deceasing levels of TNF and IFN-&#x003b3; correlate well with downregulation of Cxcl-10 in our study <a href="#pone.0008615-Williams1" rid="pone.0008615-Williams1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809896">[45]</a>. FasL and IL-2R were upregulated in the beginning of infection and deceased further. FasL is known to induce apoptosis in brain cells during viral encephalitis <a href="#pone.0008615-Clarke1" rid="pone.0008615-Clarke1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_671809898">[46]</a>.</p><p id="__p65">The gene profiling results clearly demonstrate that none of the genes modulated during the course of CHPV infection were affected in P-2 siRNA treated mice confirming that the siRNA did not allow replication of CHPV (real time and histopathology also scored the brains as negative for CHPV) and therefore did not lead to the cascade of immune reactions leading either to recovery or death. Absence of anti-CHP antibodies provides similar evidence.</p><p id="__p66" class="p p-last">In a nutshell, we report the identification of an efficient siRNA that can potently protect mice against lethal encephalitis induced by CHPV and utility of the cationic lipids for effective brain delivery. This preliminary but important finding should be taken to its logical conclusion by conducting additional studies mentioned earlier including trial in rhesus monkeys.</p></div><div id="idm139860001857008" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139860001857008title">Acknowledgments</h2><div class="sec"><p id="__p67">Satyendra Kumar acknowledges University Grant commission (UGC), Government of India, for SRF.</p></div></div><div id="idm139860001856272" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139860001856272title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139860001856144"><p id="__p68" class="p p-first-last"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></p><p class="fn sec" id="idm139860001855024"><p id="__p69" class="p p-first-last"><strong>Funding: </strong>The study was supported by the Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></p></div></div><div id="idm139860040926016" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139860040926016title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0008615-Rao1">1. <span class="element-citation">Rao BL, Basu A, Wairagkar NS, Gore MM, Arankalle VA, et al.  A large outbreak of acute encephalitis with high case fatality rate in children in Andhra Pradesh, India in 2003 associated with Chandipura virus. <span><span class="ref-journal">Lancet. </span>2004;<span class="ref-vol">364</span>:869\xe2\x80\x93874.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7137741/">PMC free article</a>]</span> [<a href="/pubmed/15351194" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=A+large+outbreak+of+acute+encephalitis+with+high+case+fatality+rate+in+children+in+Andhra+Pradesh,+India+in+2003+associated+with+Chandipura+virus.&amp;author=BL+Rao&amp;author=A+Basu&amp;author=NS+Wairagkar&amp;author=MM+Gore&amp;author=VA+Arankalle&amp;volume=364&amp;publication_year=2004&amp;pages=869-874&amp;pmid=15351194&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Chadha1">2. <span class="element-citation">Chadha MS, Arankalle VA, Jadi RS, Joshi MV, Thakare JP, et al.  An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat state, India. <span><span class="ref-journal">Am J Trop Med. </span>2005;<span class="ref-vol">73</span>:566\xe2\x80\x93570.</span> [<a href="/pubmed/16172482" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Trop+Med&amp;title=An+outbreak+of+Chandipura+virus+encephalitis+in+the+eastern+districts+of+Gujarat+state,+India.&amp;author=MS+Chadha&amp;author=VA+Arankalle&amp;author=RS+Jadi&amp;author=MV+Joshi&amp;author=JP+Thakare&amp;volume=73&amp;publication_year=2005&amp;pages=566-570&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Tandale1">3. <span class="element-citation">Tandale BV, Tikute SS, Arankalle VA, Sathe PS, Joshi MV, et al.  Chandipura virus: a major cause of acute encephalitis in children in North Telangana, Andhra Pradesh, India. <span><span class="ref-journal">J Med Virol. </span>2008;<span class="ref-vol">80</span>:118\xe2\x80\x9324.</span> [<a href="/pubmed/18041027" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Virol&amp;title=Chandipura+virus:+a+major+cause+of+acute+encephalitis+in+children+in+North+Telangana,+Andhra+Pradesh,+India.&amp;author=BV+Tandale&amp;author=SS+Tikute&amp;author=VA+Arankalle&amp;author=PS+Sathe&amp;author=MV+Joshi&amp;volume=80&amp;publication_year=2008&amp;pages=118-24&amp;pmid=18041027&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Basak1">4. <span class="element-citation">Basak S, Mondal A, Polley S, Mukhopadhyay S, Chattopadhyay D. Reviewing Chandipura: a vesiculovirus in human epidemics. <span><span class="ref-journal">Biosci Rep 27. </span>2007;<span class="ref-vol">(4-5)</span>:275\xe2\x80\x9398.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7087735/">PMC free article</a>]</span> [<a href="/pubmed/17610154" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biosci+Rep+27&amp;title=Reviewing+Chandipura:+a+vesiculovirus+in+human+epidemics.&amp;author=S+Basak&amp;author=A+Mondal&amp;author=S+Polley&amp;author=S+Mukhopadhyay&amp;author=D+Chattopadhyay&amp;volume=(4-5)&amp;publication_year=2007&amp;pages=275-98&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Dixon1">5. <span class="element-citation">Dixon RA. Natural products and plant disease resistance. <span><span class="ref-journal">Nature. </span>2001;<span class="ref-vol">411</span>:843\xe2\x80\x93847.</span> [<a href="/pubmed/11459067" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Natural+products+and+plant+disease+resistance.&amp;author=RA+Dixon&amp;volume=411&amp;publication_year=2001&amp;pages=843-847&amp;pmid=11459067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Tijsterman1">6. <span class="element-citation">Tijsterman M, Ketting RF, Plasterk RH. The genetics of RNA silencing. <span><span class="ref-journal">Annu Rev Genet. </span>2002;<span class="ref-vol">36</span>:489\xe2\x80\x93519.</span> [<a href="/pubmed/12429701" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Genet&amp;title=The+genetics+of+RNA+silencing.&amp;author=M+Tijsterman&amp;author=RF+Ketting&amp;author=RH+Plasterk&amp;volume=36&amp;publication_year=2002&amp;pages=489-519&amp;pmid=12429701&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Plasterk1">7. <span class="element-citation">Plasterk RH. RNA silencing: The genome\'s immune system. <span><span class="ref-journal">Science. </span>2002;<span class="ref-vol">296</span>:1263\xe2\x80\x931265.</span> [<a href="/pubmed/12016302" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=RNA+silencing:+The+genome\'s+immune+system.&amp;author=RH+Plasterk&amp;volume=296&amp;publication_year=2002&amp;pages=1263-1265&amp;pmid=12016302&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Bernstein1">8. <span class="element-citation">Bernstein E, Denli AM, Hannon GJ. The rest is silence. <span><span class="ref-journal">RNA. </span>2001;<span class="ref-vol">7</span>:1509\xe2\x80\x931521.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1370194/">PMC free article</a>]</span> [<a href="/pubmed/11720281" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=RNA&amp;title=The+rest+is+silence.&amp;author=E+Bernstein&amp;author=AM+Denli&amp;author=GJ+Hannon&amp;volume=7&amp;publication_year=2001&amp;pages=1509-1521&amp;pmid=11720281&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Ahlquist1">9. <span class="element-citation">Ahlquist P. RNA-dependent RNA polymerases, viruses, and RNA silencing. <span><span class="ref-journal">Science. </span>2002;<span class="ref-vol">296</span>:1270\xe2\x80\x931273.</span> [<a href="/pubmed/12016304" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=RNA-dependent+RNA+polymerases,+viruses,+and+RNA+silencing.&amp;author=P+Ahlquist&amp;volume=296&amp;publication_year=2002&amp;pages=1270-1273&amp;pmid=12016304&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Mello1">10. <span class="element-citation">Mello CC, Conte D., Jr Revealing the world of RNA interference. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">431</span>:338\xe2\x80\x93342.</span> [<a href="/pubmed/15372040" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Revealing+the+world+of+RNA+interference.&amp;author=CC+Mello&amp;author=D+Conte&amp;volume=431&amp;publication_year=2004&amp;pages=338-342&amp;pmid=15372040&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Meister1">11. <span class="element-citation">Meister G, Tuschl T. Mechanisms of gene silencing by double stranded RNA. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">431</span>:343\xe2\x80\x93349.</span> [<a href="/pubmed/15372041" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Mechanisms+of+gene+silencing+by+double+stranded+RNA.&amp;author=G+Meister&amp;author=T+Tuschl&amp;volume=431&amp;publication_year=2004&amp;pages=343-349&amp;pmid=15372041&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Hannon1">12. <span class="element-citation">Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">431</span>:371\xe2\x80\x93378.</span> [<a href="/pubmed/15372045" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Unlocking+the+potential+of+the+human+genome+with+RNA+interference.&amp;author=GJ+Hannon&amp;author=JJ+Rossi&amp;volume=431&amp;publication_year=2004&amp;pages=371-378&amp;pmid=15372045&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Novina1">13. <span class="element-citation">Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, et al.  siRNA-directed inhibition of HIV-1 infection. <span><span class="ref-journal">Nat Med. </span>2002;<span class="ref-vol">8</span>:681\xe2\x80\x93686.</span> [<a href="/pubmed/12042777" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=siRNA-directed+inhibition+of+HIV-1+infection.&amp;author=CD+Novina&amp;author=MF+Murray&amp;author=DM+Dykxhoorn&amp;author=PJ+Beresford&amp;author=J+Riess&amp;volume=8&amp;publication_year=2002&amp;pages=681-686&amp;pmid=12042777&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Bennink1">14. <span class="element-citation">Bennink JR, Palmore TN. The promise of siRNAs for the treatment of influenza. <span><span class="ref-journal">Trends Mol Med. </span>2004;<span class="ref-vol">10</span>:571\xe2\x80\x93574.</span> [<a href="/pubmed/15567323" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Mol+Med&amp;title=The+promise+of+siRNAs+for+the+treatment+of+influenza.&amp;author=JR+Bennink&amp;author=TN+Palmore&amp;volume=10&amp;publication_year=2004&amp;pages=571-574&amp;pmid=15567323&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Bitko1">15. <span class="element-citation">Bitko V, Musiyenko A, Shulyayeva O, Barik S. Inhibition of respiratory viruses by nasally administered siRNA. <span><span class="ref-journal">Nat Med. </span>2005;<span class="ref-vol">11</span>:50\xe2\x80\x9355.</span> [<a href="/pubmed/15619632" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Inhibition+of+respiratory+viruses+by+nasally+administered+siRNA.&amp;author=V+Bitko&amp;author=A+Musiyenko&amp;author=O+Shulyayeva&amp;author=S+Barik&amp;volume=11&amp;publication_year=2005&amp;pages=50-55&amp;pmid=15619632&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Li1">16. <span class="element-citation">Li BJ, Tang Q, Cheng D, Qin C, Xia FY, et al.  Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. <span><span class="ref-journal">Nature Med. </span>2005;<span class="ref-vol">11</span>:944\xe2\x80\x93951.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7095788/">PMC free article</a>]</span> [<a href="/pubmed/16116432" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Med&amp;title=Using+siRNA+in+prophylactic+and+therapeutic+regimens+against+SARS+coronavirus+in+Rhesus+macaque.&amp;author=BJ+Li&amp;author=Q+Tang&amp;author=D+Cheng&amp;author=C+Qin&amp;author=FY+Xia&amp;volume=11&amp;publication_year=2005&amp;pages=944-951&amp;pmid=16116432&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Geisbert1">17. <span class="element-citation">Geisbert TW, Hansley LE, Kagan E, Yu ZE, Geisbert JB, et al.  Postexposure protection of guinea pigs against lethal ebola virus challenge is conferred by RNA interference. <span><span class="ref-journal">J Infect Dis. </span>2006;<span class="ref-vol">193</span>:1650\xe2\x80\x931657.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7110204/">PMC free article</a>]</span> [<a href="/pubmed/16703508" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Postexposure+protection+of+guinea+pigs+against+lethal+ebola+virus+challenge+is+conferred+by+RNA+interference.&amp;author=TW+Geisbert&amp;author=LE+Hansley&amp;author=E+Kagan&amp;author=ZE+Yu&amp;author=JB+Geisbert&amp;volume=193&amp;publication_year=2006&amp;pages=1650-1657&amp;pmid=16703508&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Zhang1">18. <span class="element-citation">Zhang Y, Boado RJ, Pardridge WM. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. <span><span class="ref-journal">J Gene Med. </span>2003;<span class="ref-vol">5</span>:1039\xe2\x80\x931045.</span> [<a href="/pubmed/14661179" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gene+Med&amp;title=In+vivo+knockdown+of+gene+expression+in+brain+cancer+with+intravenous+RNAi+in+adult+rats.&amp;author=Y+Zhang&amp;author=RJ+Boado&amp;author=WM+Pardridge&amp;volume=5&amp;publication_year=2003&amp;pages=1039-1045&amp;pmid=14661179&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Xia1">19. <span class="element-citation">Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, et al.  RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. <span><span class="ref-journal">Nat Med. </span>2004;<span class="ref-vol">10</span>:816\xe2\x80\x93820.</span> [<a href="/pubmed/15235598" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=RNAi+suppresses+polyglutamine-induced+neurodegeneration+in+a+model+of+spinocerebellar+ataxia.&amp;author=H+Xia&amp;author=Q+Mao&amp;author=SL+Eliason&amp;author=SQ+Harper&amp;author=IH+Martins&amp;volume=10&amp;publication_year=2004&amp;pages=816-820&amp;pmid=15235598&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Kumar1">20. <span class="element-citation">Kumar P, Lee SK, Shankar P, Manjunath N. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. <span><span class="ref-journal">PLoS Med. </span>2006;<span class="ref-vol">3</span>:505\xe2\x80\x93514.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1361782/">PMC free article</a>]</span> [<a href="/pubmed/16464133" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Med&amp;title=A+single+siRNA+suppresses+fatal+encephalitis+induced+by+two+different+flaviviruses.&amp;author=P+Kumar&amp;author=SK+Lee&amp;author=P+Shankar&amp;author=N+Manjunath&amp;volume=3&amp;publication_year=2006&amp;pages=505-514&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Barik1">21. <span class="element-citation">Barik S. Control of nonsegmented negative-strand RNA virus replication by siRNA. <span><span class="ref-journal">Virus Res. </span>2004;<span class="ref-vol">102</span>:27\xe2\x80\x9335.</span> [<a href="/pubmed/15068877" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virus+Res&amp;title=Control+of+nonsegmented+negative-strand+RNA+virus+replication+by+siRNA.&amp;author=S+Barik&amp;volume=102&amp;publication_year=2004&amp;pages=27-35&amp;pmid=15068877&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Israsena1">22. <span class="element-citation">Israsena N, Supavonwong P, Ratanasetyuth N, Khawplod P, Hemachudha T. Inhibition of Rabies Virus Replication by Multiple Artificial MicroRNAs. <span><span class="ref-journal">Antiviral Research. </span>2009</span> doi: <a href="http://dx.doi.org/10.1016/j.antiviral.2009.07.012" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">10.1016/j.antiviral.2009.07.012</a>. [<a href="/pubmed/19646485" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antiviral+Research&amp;title=Inhibition+of+Rabies+Virus+Replication+by+Multiple+Artificial+MicroRNAs.&amp;author=N+Israsena&amp;author=P+Supavonwong&amp;author=N+Ratanasetyuth&amp;author=P+Khawplod&amp;author=T+Hemachudha&amp;publication_year=2009&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Arankalle1">23. <span class="element-citation">Arankalle VA, Prabhakar SS, Madhukar WA, Hanumaih, Dattatraya PS, et al.  G, N, and P gene-based analysis of Chandipura viruses, India. <span><span class="ref-journal">Emerg Infect Dis. </span>2005;<span class="ref-vol">11</span>:123\xe2\x80\x93126.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3294343/">PMC free article</a>]</span> [<a href="/pubmed/15705335" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg+Infect+Dis&amp;title=G,+N,+and+P+gene-based+analysis+of+Chandipura+viruses,+India.&amp;author=VA+Arankalle&amp;author=SS+Prabhakar&amp;author=WA+Madhukar&amp;author=+Hanumaih&amp;author=PS+Dattatraya&amp;volume=11&amp;publication_year=2005&amp;pages=123-126&amp;pmid=15705335&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Kumar2">24. <span class="element-citation">Kumar S, Jadi RS, Anakkathil SB, Tandale BV, Mishra AC, et al.  Development and evaluation of a real-time one step Reverse-Transcriptase PCR for quantitation of Chandipura Virus. <span><span class="ref-journal">BMC Inf Dis. </span>2008;<span class="ref-vol">8</span>:168.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2629476/">PMC free article</a>]</span> [<a href="/pubmed/19091082" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Inf+Dis&amp;title=Development+and+evaluation+of+a+real-time+one+step+Reverse-Transcriptase+PCR+for+quantitation+of+Chandipura+Virus.&amp;author=S+Kumar&amp;author=RS+Jadi&amp;author=SB+Anakkathil&amp;author=BV+Tandale&amp;author=AC+Mishra&amp;volume=8&amp;publication_year=2008&amp;pages=168&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Reed1">25. <span class="element-citation">Reed LJ, Muench H. A simple method of estimating 50 percent end points. <span><span class="ref-journal">Am J Hyg. </span>1938;<span class="ref-vol">27</span>:493\xe2\x80\x9349.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hyg&amp;title=A+simple+method+of+estimating+50+percent+end+points.&amp;author=LJ+Reed&amp;author=H+Muench&amp;volume=27&amp;publication_year=1938&amp;pages=493-49&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Otsuka1">26. <span class="element-citation">Otsuka M, Jing Q, Georgel P, New L, Chen J, et al.  Hypersusceptibility to Vesicular Stomatitis Virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. <span><span class="ref-journal">Immunity. </span>2007;<span class="ref-vol">27</span>:123\xe2\x80\x93134.</span> [<a href="/pubmed/17613256" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Hypersusceptibility+to+Vesicular+Stomatitis+Virus+infection+in+Dicer1-deficient+mice+is+due+to+impaired+miR24+and+miR93+expression.&amp;author=M+Otsuka&amp;author=Q+Jing&amp;author=P+Georgel&amp;author=L+New&amp;author=J+Chen&amp;volume=27&amp;publication_year=2007&amp;pages=123-134&amp;pmid=17613256&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Chattopadhyay1">27. <span class="element-citation">Chattopadhyay D, Chattopadhyay D. Cloning of the Chandipura virus phosphoprotein encoding gene and its expression in <em>Escherichia coli</em>. <span><span class="ref-journal">Cell Mol Biol Res. </span>1994;<span class="ref-vol">40</span>:693\xe2\x80\x93698.</span> [<a href="/pubmed/7787887" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Biol+Res&amp;title=Cloning+of+the+Chandipura+virus+phosphoprotein+encoding+gene+and+its+expression+in+Escherichia+coli.&amp;author=D+Chattopadhyay&amp;author=D+Chattopadhyay&amp;volume=40&amp;publication_year=1994&amp;pages=693-698&amp;pmid=7787887&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Venkateswarlu1">28. <span class="element-citation">Venkateswarlu CH, Arankalle VA. Recombinant glycoprotein based vaccine for Chandipura virus infection. <span><span class="ref-journal">Vaccine. </span>2009;<span class="ref-vol">27(21)</span>:2845\xe2\x80\x9350.</span> [<a href="/pubmed/19428894" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Recombinant+glycoprotein+based+vaccine+for+Chandipura+virus+infection.&amp;author=CH+Venkateswarlu&amp;author=VA+Arankalle&amp;volume=27(21)&amp;publication_year=2009&amp;pages=2845-50&amp;pmid=19428894&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Licata1">29. <span class="element-citation">Licata JM, Harty RN. Rhabdoviruses and apoptosis. <span><span class="ref-journal">Int Rev Immunol. </span>2003;<span class="ref-vol">22</span>:451\xe2\x80\x93476.</span> [<a href="/pubmed/12959754" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+Rev+Immunol&amp;title=Rhabdoviruses+and+apoptosis.&amp;author=JM+Licata&amp;author=RN+Harty&amp;volume=22&amp;publication_year=2003&amp;pages=451-476&amp;pmid=12959754&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Hutvagner1">30. <span class="element-citation">Hutvagner G, Simard MJ, Mello CC, Zamore PD. Sequence-specific inhibition of small RNA function. <span><span class="ref-journal">PLoS Biol. </span>2004;<span class="ref-vol">2</span>:e98.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC350664/">PMC free article</a>]</span> [<a href="/pubmed/15024405" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Biol&amp;title=Sequence-specific+inhibition+of+small+RNA+function.&amp;author=G+Hutvagner&amp;author=MJ+Simard&amp;author=CC+Mello&amp;author=PD+Zamore&amp;volume=2&amp;publication_year=2004&amp;pages=e98&amp;pmid=15024405&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Fulton1">31. <span class="element-citation">Fulton A, Peters ST, Perkins GA, Jarosinski KW, Damiani A, et al.  Effective treatment of respiratory alphaherpesvirus infection using RNA interference. <span><span class="ref-journal">PLoS ONE. </span>2009;<span class="ref-vol">4</span>:e4118.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2606062/">PMC free article</a>]</span> [<a href="/pubmed/19122813" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Effective+treatment+of+respiratory+alphaherpesvirus+infection+using+RNA+interference.&amp;author=A+Fulton&amp;author=ST+Peters&amp;author=GA+Perkins&amp;author=KW+Jarosinski&amp;author=A+Damiani&amp;volume=4&amp;publication_year=2009&amp;pages=e4118&amp;pmid=19122813&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Elbashir1">32. <span class="element-citation">Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. <span><span class="ref-journal">EMBO J. </span>2001;<span class="ref-vol">c 3; 20</span>:6877\xe2\x80\x936888.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC125328/">PMC free article</a>]</span> [<a href="/pubmed/11726523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J&amp;title=Functional+anatomy+of+siRNAs+for+mediating+efficient+RNAi+in+Drosophila+melanogaster+embryo+lysate.&amp;author=SM+Elbashir&amp;author=J+Martinez&amp;author=A+Patkaniowska&amp;author=W+Lendeckel&amp;author=T+Tuschl&amp;volume=c+3;+20&amp;publication_year=2001&amp;pages=6877-6888&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Brummelkamp1">33. <span class="element-citation">Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. <span><span class="ref-journal">Science. </span>2002;<span class="ref-vol">296</span>:550\xe2\x80\x93553.</span> [<a href="/pubmed/11910072" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=A+system+for+stable+expression+of+short+interfering+RNAs+in+mammalian+cells.&amp;author=TR+Brummelkamp&amp;author=R+Bernards&amp;author=R+Agami&amp;volume=296&amp;publication_year=2002&amp;pages=550-553&amp;pmid=11910072&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Taylor1">34. <span class="element-citation">Taylor A, Easton AJ, Marriott AC. Matrix protein of Chandipura virus inhibits transcription from an RNA polymerase II promoter. <span><span class="ref-journal">Virus Genes. </span>1999;<span class="ref-vol">19</span>:223\xe2\x80\x93228.</span> [<a href="/pubmed/10595413" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virus+Genes&amp;title=Matrix+protein+of+Chandipura+virus+inhibits+transcription+from+an+RNA+polymerase+II+promoter.&amp;author=A+Taylor&amp;author=AJ+Easton&amp;author=AC+Marriott&amp;volume=19&amp;publication_year=1999&amp;pages=223-228&amp;pmid=10595413&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Ahmed1">35. <span class="element-citation">Ahmed M, Lyles DS. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III. <span><span class="ref-journal">J Virol. </span>1998;<span class="ref-vol">72</span>:8413\xe2\x80\x938419.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC110232/">PMC free article</a>]</span> [<a href="/pubmed/9733895" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Effect+of+vesicular+stomatitis+virus+matrix+protein+on+transcription+directed+by+host+RNA+polymerases+I,+II,+and+III.&amp;author=M+Ahmed&amp;author=DS+Lyles&amp;volume=72&amp;publication_year=1998&amp;pages=8413-8419&amp;pmid=9733895&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Ghodgaonkar1">36. <span class="element-citation">Ghodgaonkar MM, Shah RG, Kandan-Kulangara F, Affar E-B, Qi HH, et al.  Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1. <span><span class="ref-journal">Cell Death and Differentiation. </span>2009;<span class="ref-vol">16</span>:858\xe2\x80\x9368.</span> [<a href="/pubmed/19229243" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+and+Differentiation&amp;title=Abrogation+of+DNA+vector-based+RNAi+during+apoptosis+in+mammalian+cells+due+to+caspase-mediated+cleavage+and+inactivation+of+Dicer-1.&amp;author=MM+Ghodgaonkar&amp;author=RG+Shah&amp;author=F+Kandan-Kulangara&amp;author=E-B+Affar&amp;author=HH+Qi&amp;volume=16&amp;publication_year=2009&amp;pages=858-68&amp;pmid=19229243&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Dorn1">37. <span class="element-citation">Dorn G, Patel S, Wotherspoon G, Hemmings-Mieszczak M, Barclay J, et al.  siRNA relieves chronic neuropathic pain. <span><span class="ref-journal">Nucleic Acids Res. </span>2004;<span class="ref-vol">32</span>:e49.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC390346/">PMC free article</a>]</span> [<a href="/pubmed/15026538" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=siRNA+relieves+chronic+neuropathic+pain.&amp;author=G+Dorn&amp;author=S+Patel&amp;author=G+Wotherspoon&amp;author=M+Hemmings-Mieszczak&amp;author=J+Barclay&amp;volume=32&amp;publication_year=2004&amp;pages=e49&amp;pmid=15026538&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Isacson1">38. <span class="element-citation">Isacson R, Kull B, Salmi P, Wahlestedt C. Lack of efficacy of &#x0201c;naked&#x0201d; small interfering RNA applied directly to rat brain. <span><span class="ref-journal">Acta Physiol Scand. </span>2003;<span class="ref-vol">179</span>:173\xe2\x80\x93177.</span> [<a href="/pubmed/14510781" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Physiol+Scand&amp;title=Lack+of+efficacy+of+&#x0201c;naked&#x0201d;+small+interfering+RNA+applied+directly+to+rat+brain.&amp;author=R+Isacson&amp;author=B+Kull&amp;author=P+Salmi&amp;author=C+Wahlestedt&amp;volume=179&amp;publication_year=2003&amp;pages=173-177&amp;pmid=14510781&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Lingor1">39. <span class="element-citation">Lingor P, Michel U, Scholl U, Bahr M, Kugler S. Transfection of &#x0201c;naked&#x0201d; siRNA results in endosomal uptake and metabolic impairment in cultured neurons. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2004;<span class="ref-vol">315</span>:1126\xe2\x80\x931133.</span> [<a href="/pubmed/14985130" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Transfection+of+&#x0201c;naked&#x0201d;+siRNA+results+in+endosomal+uptake+and+metabolic+impairment+in+cultured+neurons.&amp;author=P+Lingor&amp;author=U+Michel&amp;author=U+Scholl&amp;author=M+Bahr&amp;author=S+Kugler&amp;volume=315&amp;publication_year=2004&amp;pages=1126-1133&amp;pmid=14985130&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Koterski1">40. <span class="element-citation">Koterski J, Twenhafel N, Porter A, Reed DS, Martino-Catt S, et al.  Gene expression profiling of nonhuman primates exposed to aerosolized Venezuelan equine encephalitis virus. <span><span class="ref-journal">FEMS Immunol Med Microbiol. </span>2007;<span class="ref-vol">51(3)</span>:462\xe2\x80\x9372.</span> [<a href="/pubmed/17894805" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEMS+Immunol+Med+Microbiol&amp;title=Gene+expression+profiling+of+nonhuman+primates+exposed+to+aerosolized+Venezuelan+equine+encephalitis+virus.&amp;author=J+Koterski&amp;author=N+Twenhafel&amp;author=A+Porter&amp;author=DS+Reed&amp;author=S+Martino-Catt&amp;volume=51(3)&amp;publication_year=2007&amp;pages=462-72&amp;pmid=17894805&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Trottier1">41. <span class="element-citation">Trottier MD, Jr, Palian BM, Reiss CS. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. <span><span class="ref-journal">Virology. </span>2005;<span class="ref-vol">333(2)</span>:215\xe2\x80\x9325.</span> [<a href="/pubmed/15721356" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=VSV+replication+in+neurons+is+inhibited+by+type+I+IFN+at+multiple+stages+of+infection.&amp;author=MD+Trottier&amp;author=BM+Palian&amp;author=CS+Reiss&amp;volume=333(2)&amp;publication_year=2005&amp;pages=215-25&amp;pmid=15721356&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Tripathy1">42. <span class="element-citation">Tripathy A, Balaji S, Rao N, Thakare J, Mishra A, et al.  Cytokine levels in Chandipura virus associated encephalopathy in children. <span><span class="ref-journal">Scand J Infect Dis. </span>2005;<span class="ref-vol">37(8)</span>:590\xe2\x80\x933.</span> [<a href="/pubmed/16099769" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand+J+Infect+Dis&amp;title=Cytokine+levels+in+Chandipura+virus+associated+encephalopathy+in+children.&amp;author=A+Tripathy&amp;author=S+Balaji&amp;author=N+Rao&amp;author=J+Thakare&amp;author=A+Mishra&amp;volume=37(8)&amp;publication_year=2005&amp;pages=590-3&amp;pmid=16099769&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Sergerie1">43. <span class="element-citation">Sergerie Y, Rivest S, Boivin G. Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis. <span><span class="ref-journal">J Infect Dis. </span>2007;<span class="ref-vol">196(6)</span>:853\xe2\x80\x9360.</span> [<a href="/pubmed/17703415" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Tumor+necrosis+factor-alpha+and+interleukin-1+beta+play+a+critical+role+in+the+resistance+against+lethal+herpes+simplex+virus+encephalitis.&amp;author=Y+Sergerie&amp;author=S+Rivest&amp;author=G+Boivin&amp;volume=196(6)&amp;publication_year=2007&amp;pages=853-60&amp;pmid=17703415&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Nuovo1">44. <span class="element-citation">Nuovo GJ, Defaria DL, Chanona-Vilchi JG, Zhang Y. Molecular detection of rabies encephalitis and correlation with cytokine expression. <span><span class="ref-journal">Mod Pathol. </span>2005;<span class="ref-vol">18(1)</span>:62\xe2\x80\x937.</span> [<a href="/pubmed/15389258" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mod+Pathol&amp;title=Molecular+detection+of+rabies+encephalitis+and+correlation+with+cytokine+expression.&amp;author=GJ+Nuovo&amp;author=DL+Defaria&amp;author=JG+Chanona-Vilchi&amp;author=Y+Zhang&amp;volume=18(1)&amp;publication_year=2005&amp;pages=62-7&amp;pmid=15389258&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Williams1">45. <span class="element-citation">Williams R, Yao H, Dhillon NK, Buch SJ. HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes. <span><span class="ref-journal">PLoS One. </span>2009;<span class="ref-vol">4(5)</span>:e5709.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2684622/">PMC free article</a>]</span> [<a href="/pubmed/19479051" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=HIV-1+Tat+co-operates+with+IFN-gamma+and+TNF-alpha+to+increase+CXCL10+in+human+astrocytes.&amp;author=R+Williams&amp;author=H+Yao&amp;author=NK+Dhillon&amp;author=SJ+Buch&amp;volume=4(5)&amp;publication_year=2009&amp;pages=e5709&amp;pmid=19479051&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0008615-Clarke1">46. <span class="element-citation">Clarke P, Beckham JD, Leser JS, Hoyt CC, Tyler KL. Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. <span><span class="ref-journal">J Virol. </span>2009;<span class="ref-vol">83</span>:6161\xe2\x80\x936170.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2687381/">PMC free article</a>]</span> [<a href="/pubmed/19321603" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Fas-mediated+apoptotic+signaling+in+the+mouse+brain+following+reovirus+infection.&amp;author=P+Clarke&amp;author=JD+Beckham&amp;author=JS+Leser&amp;author=CC+Hoyt&amp;author=KL+Tyler&amp;volume=83&amp;publication_year=2009&amp;pages=6161-6170&amp;pmid=19321603&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2797643&amp;issue-id=183607&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2797643/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2797643/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2797643/pdf/pone.0008615.pdf">PDF (1.2M)</a></li> | <li><a href="#" data-citationid="PMC2797643" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2797643%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2797643%2F&amp;text=Intracranial%20Administration%20of%20P%20Gene%20siRNA%20Protects%20Mice%20from%20Lethal%20Chandipura%20Virus%20Encephalitis"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2797643%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="20062542" data-aiid="2797643" data-aid="2797643" data-iid="183607" data-domainid="440" data-domain="plosone" data-accid="PMC2797643" data-md5="e4a2700d9cacfe8de55de6f76cae152c"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:29:27-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BA949E9A44401000000000290028F&amp;ncbi_session=8A1BA949E9A49E61_0656SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2797643%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plosone&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2797643/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BA949E9A49E61_0656SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'